Abstract
Ensuring biosafety in the territory of the country is one of the key functions (tasks) of the state. The pandemic of a new coronavirus infection has affected absolutely all areas of human activity in all countries of the world. Approaches to prevention have not changed, but the whole country has faced a number of challenges at various levels. With a sharply increased demand for non-specific prophylaxis (including skin antiseptics and disinfectants), not all manufacturers were ready to meet the demand with a quality product. The scarcity of resources (raw materials, components, cash shortages, personnel, etc.) constrained the rapid increase in production capacity to ensure a sharply increased demand. Keywords: pandemic COVID-19, disinfectants, skin antiseptics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
